Cargando…

Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery

The lack of biologically relevant protein structures can hinder rational design of small molecules to target G protein-coupled receptors (GPCRs). While ensemble docking using multiple models of the protein target is a promising technique for structure-based drug discovery, model clustering and selec...

Descripción completa

Detalles Bibliográficos
Autores principales: McKay, Kyle, Hamilton, Nicholas B., Remington, Jacob M., Schneebeli, Severin T., Li, Jianing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277106/
https://www.ncbi.nlm.nih.gov/pubmed/35847975
http://dx.doi.org/10.3389/fmolb.2022.879212
_version_ 1784745880532811776
author McKay, Kyle
Hamilton, Nicholas B.
Remington, Jacob M.
Schneebeli, Severin T.
Li, Jianing
author_facet McKay, Kyle
Hamilton, Nicholas B.
Remington, Jacob M.
Schneebeli, Severin T.
Li, Jianing
author_sort McKay, Kyle
collection PubMed
description The lack of biologically relevant protein structures can hinder rational design of small molecules to target G protein-coupled receptors (GPCRs). While ensemble docking using multiple models of the protein target is a promising technique for structure-based drug discovery, model clustering and selection still need further investigations to achieve both high accuracy and efficiency. In this work, we have developed an original ensemble docking approach, which identifies the most relevant conformations based on the essential dynamics of the protein pocket. This approach is applied to the study of small-molecule antagonists for the PAC1 receptor, a class B GPCR and a regulator of stress. As few as four representative PAC1 models are selected from simulations of a homology model and then used to screen three million compounds from the ZINC database and 23 experimentally validated compounds for PAC1 targeting. Our essential dynamics ensemble docking (EDED) approach can effectively reduce the number of false negatives in virtual screening and improve the accuracy to seek potent compounds. Given the cost and difficulties to determine membrane protein structures for all the relevant states, our methodology can be useful for future discovery of small molecules to target more other GPCRs, either with or without experimental structures.
format Online
Article
Text
id pubmed-9277106
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92771062022-07-14 Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery McKay, Kyle Hamilton, Nicholas B. Remington, Jacob M. Schneebeli, Severin T. Li, Jianing Front Mol Biosci Molecular Biosciences The lack of biologically relevant protein structures can hinder rational design of small molecules to target G protein-coupled receptors (GPCRs). While ensemble docking using multiple models of the protein target is a promising technique for structure-based drug discovery, model clustering and selection still need further investigations to achieve both high accuracy and efficiency. In this work, we have developed an original ensemble docking approach, which identifies the most relevant conformations based on the essential dynamics of the protein pocket. This approach is applied to the study of small-molecule antagonists for the PAC1 receptor, a class B GPCR and a regulator of stress. As few as four representative PAC1 models are selected from simulations of a homology model and then used to screen three million compounds from the ZINC database and 23 experimentally validated compounds for PAC1 targeting. Our essential dynamics ensemble docking (EDED) approach can effectively reduce the number of false negatives in virtual screening and improve the accuracy to seek potent compounds. Given the cost and difficulties to determine membrane protein structures for all the relevant states, our methodology can be useful for future discovery of small molecules to target more other GPCRs, either with or without experimental structures. Frontiers Media S.A. 2022-06-29 /pmc/articles/PMC9277106/ /pubmed/35847975 http://dx.doi.org/10.3389/fmolb.2022.879212 Text en Copyright © 2022 McKay, Hamilton, Remington, Schneebeli and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
McKay, Kyle
Hamilton, Nicholas B.
Remington, Jacob M.
Schneebeli, Severin T.
Li, Jianing
Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery
title Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery
title_full Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery
title_fullStr Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery
title_full_unstemmed Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery
title_short Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery
title_sort essential dynamics ensemble docking for structure-based gpcr drug discovery
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277106/
https://www.ncbi.nlm.nih.gov/pubmed/35847975
http://dx.doi.org/10.3389/fmolb.2022.879212
work_keys_str_mv AT mckaykyle essentialdynamicsensembledockingforstructurebasedgpcrdrugdiscovery
AT hamiltonnicholasb essentialdynamicsensembledockingforstructurebasedgpcrdrugdiscovery
AT remingtonjacobm essentialdynamicsensembledockingforstructurebasedgpcrdrugdiscovery
AT schneebeliseverint essentialdynamicsensembledockingforstructurebasedgpcrdrugdiscovery
AT lijianing essentialdynamicsensembledockingforstructurebasedgpcrdrugdiscovery